| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene Expression in Activated Alveolar Macrophages: Decreased NF-
B Activation and IB Kinase Activity1
Department of Developmental Biochemistry, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY 10314
Taurine prevents tissue damage in a variety of models that involve
inflammation, including oxidant-induced lung damage. The mechanism of
protection is uncertain, but is postulated to involve the actions of
taurine chloramine (Tau-Cl) derived via halide-dependent
myeloperoxidase associated with neutrophils. Understanding the
influence of Tau-Cl on the production of inflammatory mediators by
alveolar macrophages provides an opportunity for determining the
mechanism of Tau-Cl action. The effects of Tau-Cl were evaluated on the
production of NO and TNF-
in NR8383, a cloned cell line derived from
rat alveolar macrophages (RAM), and in primary cultures of RAM.
Production of NO and TNF-, and expression of inducible NO synthase
was inhibited by Tau-Cl in activated NR8383 cells as well as in RAM.
Temporal (2, 4, 8, 24 h) expression of inducible NO synthase and
TNF- mRNAs was reduced by Tau-Cl in NR8383 cells. Tau-Cl depressed
NF-
B migration into the nucleus of activated NR8383 cells and caused
a more sustained presence of IB in the cytoplasm. Stabilization of
cytoplasmic IB- in Tau-Cl-treated cells resulted from decreased
phosphorylation of IB- serine-32 and a lower activity of IB
kinase (IKK). Additional experiments demonstrated that Tau-Cl does not
directly inhibit IKK activity. These results suggest that Tau-Cl exerts
its effects at some level upstream of IKK in the signaling pathway and
inhibits production of inflammatory mediators through a mechanism that,
at least in part, involves inhibition of NF-B
activation.
This article has been cited by other articles:
|
|
 |
|
  T. K. Davtyan, I. S. Hakobyan, R. E. Muradyan, H. G. Hovhannisyan, and E. S. Gabrielyan Evaluation of amino acids as mediators for the antibacterial activity of iodine-lithium-{alpha}-dextrin in vitro and in vivo J. Antimicrob. Chemother., June 1, 2007; 59(6): 1114 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kim, H. Jeon, H. Kong, Y. Yang, B. Choi, Y. M. Kim, L. Neckers, and Y. Jung A Molecular Mechanism for the Anti-Inflammatory Effect of Taurine-Conjugated 5-Aminosalicylic Acid in Inflamed Colon Mol. Pharmacol., April 1, 2006; 69(4): 1405 - 1412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Emerson, M. L. McCormick, J. A. Schmidt, and C. M. Knudson Taurine Monochloramine Activates a Cell Death Pathway Involving Bax and Caspase-9 J. Biol. Chem., February 4, 2005; 280(5): 3233 - 3241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mainnemare, B. Megarbane, A. Soueidan, A. Daniel, and I.L.C. Chapple Hypochlorous Acid and Taurine-N-Monochloramine in Periodontal Diseases Journal of Dental Research, November 1, 2004; 83(11): 823 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Midwinter, A. V. Peskin, M. C. M. Vissers, and C. C. Winterbourn Extracellular Oxidation by Taurine Chloramine Activates ERK via the Epidermal Growth Factor Receptor J. Biol. Chem., July 30, 2004; 279(31): 32205 - 32211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mohri, P. S. Reinach, A. Kanayama, M. Shimizu, J. Moskovitz, T. Hisatsune, and Y. Miyamoto Suppression of the TNF{alpha}-Induced Increase in IL-1{alpha} Expression by Hypochlorite in Human Corneal Epithelial Cells Invest. Ophthalmol. Vis. Sci., October 1, 2002; 43(10): 3190 - 3195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kanayama, J.-i. Inoue, Y. Sugita-Konishi, M. Shimizu, and Y. Miyamoto Oxidation of Ikappa Balpha at Methionine 45 Is One Cause of Taurine Chloramine-induced Inhibition of NF-kappa B Activation J. Biol. Chem., June 28, 2002; 277(27): 24049 - 24056. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
